Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Cardiac Function and Cardiovascular Risk Profile in Testicular Cancer Patients
This study is currently recruiting participants.
Verified by Alberta Cancer Board, January 2009
Sponsored by: Alberta Cancer Board
Information provided by: Alberta Cancer Board
ClinicalTrials.gov Identifier: NCT00705094
  Purpose

For many years, researchers and doctors have studied different kinds of treatments to improve the survival of men with testicular cancer. However, recent research has shown that many years later, men who had testicular cancer appear to be at higher risk for developing heart disease (heart attack or heart failure), especially if they received chemotherapy. Since these studies were done many years after men received treatment, there was no way to know if other factors contributed to the health problems they experienced. This study is being done because it would be helpful to study heart function and cardiovascular disease risk factors of men who have been diagnosed with testicular cancer, before and after they receive chemotherapy treatment compared to men who receive treatment with surgery alone.


Condition
Testicular Cancer
Seminoma
Non-Seminomatous

MedlinePlus related topics: Cancer Testicular Cancer
U.S. FDA Resources
Study Type: Observational
Study Design: Case Control, Prospective
Official Title: Cardiac Function and Cardiovascular Risk Profile in Testicular Cancer Patients

Further study details as provided by Alberta Cancer Board:

Biospecimen Retention:   None Retained

Biospecimen Description:

Estimated Enrollment: 30
Study Start Date: September 2008
Estimated Primary Completion Date: September 2009 (Final data collection date for primary outcome measure)
Groups/Cohorts
1
Testicular cancer patients who have received surgery and are scheduled for surveillance
2
Testicular cancer patients who have received surgery and are scheduled for chemotherapy

Detailed Description:

The aim of this pilot study is to examine global and regional LV systolic and diastolic function, cardiac output, cardiac reserve, VO2peak and CVD risk profile in males recently diagnosed with testicular cancer treated with surgery alone or surgery and chemotherapy.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

testicular cancer patients who have recieved surgery and are scheduled for either chemotherapy or surveillance

Criteria

Inclusion Criteria:

  • surgery and surveillance
  • surgery and multi-cycle chemotherapy
  • both good and intermediate prognosis seminoma and non-seminomatous germ cell testicular tumors
  • Karnofsky performance index > 70%
  • no contraindications to cardiopulmonary testing

Exclusion Criteria:

  • documented cardiovascular disease or evidence of myocardial ischemia on the incremental exercise (VO2peak) test.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00705094

Contacts
Contact: Edith Pituskin, RN, PhD Student (780) 432 - 8792 pituskin@ualberta.ca

Locations
Canada, Alberta
Cross Cancer Institute Recruiting
Edmonton, Alberta, Canada, T6G 1Z2
Contact: Clinical Research Unit     780-989-8152     clinical_trials_cci@cancerboard.ab.ca    
Principal Investigator: Mark Haykowsky, PhD            
Sponsors and Collaborators
Alberta Cancer Board
Investigators
Principal Investigator: Mark Haykowsky, PhD University of Alberta
  More Information

Responsible Party: University of Alberta ( Mark Haykowsky, PhD )
Study ID Numbers: GU-24167
Study First Received: June 23, 2008
Last Updated: January 12, 2009
ClinicalTrials.gov Identifier: NCT00705094  
Health Authority: Canada: Canadian Institutes of Health Research

Keywords provided by Alberta Cancer Board:
cardiovascular risk factors
cardiac function
VO2peak
Chemotherapy

Study placed in the following topic categories:
Genital Neoplasms, Male
Gonadal Disorders
Neoplasms, Germ Cell and Embryonal
Testicular Diseases
Endocrine System Diseases
Seminoma
Testicular cancer
Urogenital Neoplasms
Endocrinopathy
Testicular Neoplasms
Genital Diseases, Male
Endocrine Gland Neoplasms

Additional relevant MeSH terms:
Neoplasms
Neoplasms by Site
Neoplasms by Histologic Type
Germinoma

ClinicalTrials.gov processed this record on January 16, 2009